2018
Phenotypic Screening Using Patient-Derived Induced Pluripotent Stem Cells Identified Pyr3 as a Candidate Compound for the Treatment of Infantile Hypertrophic Cardiomyopathy
Sakai T, Naito AT, Kuramoto Y, Ito M, Okada K, Higo T, Nakagawa A, Shibamoto M, Yamaguchi T, Sumida T, Nomura S, Umezawa A, Miyagawa S, Sawa Y, Morita H, Lee JK, Shiojima I, Sakata Y, Komuro I. Phenotypic Screening Using Patient-Derived Induced Pluripotent Stem Cells Identified Pyr3 as a Candidate Compound for the Treatment of Infantile Hypertrophic Cardiomyopathy. International Heart Journal 2018, 59: 17-730. PMID: 30101858, DOI: 10.1536/ihj.17-730.Peer-Reviewed Original ResearchConceptsDiastolic intracellular calcium concentrationInfantile hypertrophic cardiomyopathyHypertrophic cardiomyopathyIntracellular calcium concentrationHCM patientsIPSC-CMsInduced pluripotent stem cellsNoonan syndromeCalcium concentrationIdiopathic hypertrophic cardiomyopathyPatient-derived induced pluripotent stem cellsStem cellsPluripotent stem cellsHealthy subjectsPatientsChannel inhibitorsPhenotypic screeningPyr3Genetic disordersDisease-related phenotypesCardiomyopathySyndromeCandidate compoundsPresent studyTreatment
2015
Generation of Induced Pluripotent Stem Cells From Patients With Duchenne Muscular Dystrophy and Their Induction to Cardiomyocytes
Hashimoto A, Naito AT, Lee JK, Kitazume-Taneike R, Ito M, Yamaguchi T, Nakata R, Sumida T, Okada K, Nakagawa A, Higo T, Kuramoto Y, Sakai T, Tominaga K, Okinaga T, Kogaki S, Ozono K, Miyagawa S, Sawa Y, Sakata Y, Morita H, Umezawa A, Komuro I. Generation of Induced Pluripotent Stem Cells From Patients With Duchenne Muscular Dystrophy and Their Induction to Cardiomyocytes. International Heart Journal 2015, 57: 112-117. PMID: 26673445, DOI: 10.1536/ihj.15-376.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCell DifferentiationCells, CulturedHumansInduced Pluripotent Stem CellsMuscular Dystrophy, DuchenneMyocytes, CardiacReal-Time Polymerase Chain ReactionRNAConceptsDuchenne muscular dystrophyDMD patientsMuscular dystrophyYears of ageIPS cell-derived cardiomyocytesPatient-specific iPS cellsDMD cardiomyopathyCardiac dysfunctionCurative treatmentCell-derived cardiomyocytesT lymphocytesPatientsCardiac phenotypeSendai virus vectorCardiac muscleSkeletal muscleDystrophin defectsInduced pluripotent stem cellsCardiomyocytesCell linesStem cellsDystrophin proteinDystrophyPluripotent stem cellsMuscle